7月23日中银创新医疗混合A净值下跌0.96%，近1个月累计上涨13.58%

Group 1 - The core point of the article highlights the performance and holdings of the Zhongyin Innovation Medical Mixed A fund, which has shown significant returns over various time frames, including a 76.52% return year-to-date [1] - The fund's recent net value is reported at 2.1241 yuan, with a slight decline of 0.96% [1] - The fund's performance rankings are notable, with a 13.58% return over the past month (ranked 488 out of 4001), an 80.76% return over the past six months (ranked 25 out of 3880), and a 76.52% return year-to-date (ranked 26 out of 3861) [1] Group 2 - The top ten stock holdings of the Zhongyin Innovation Medical Mixed A fund account for a total of 62.83%, with significant positions in companies such as Innovent Biologics (8.33%), Kelun-Biotech (8.15%), and Hengrui Medicine (8.08%) [1] - The fund was established on November 13, 2019, and as of June 30, 2025, it has a total scale of 1.266 billion yuan [1] - The fund manager, Zheng Ning, has a background in stock research and has held various positions in asset management companies before joining Zhongyin Fund Management in 2022 [2]